SCHEMBL2274953

SCHEMBL2274953

O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)c1ccc(F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.67
DHODH Q02127 1/20 0.67
HDAC2 Q92769 3/20 0.65
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
SERPINE1 P05121 1/20 0.58
HDAC1 Q13547 5/20 0.57
HDAC3 O15379 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
MAPT P10636 1/20 0.55
PKM P14618 1/20 0.55
GRIK1 P39086 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
SUCNR1 Q9BXA5 1/20 0.54
ADCY8 P40145 1/20 0.54
ADCY1 Q08828 1/20 0.54
IGF2BP2 Q9Y6M1 1/20 0.54
PTPN1 P18031 1/20 0.53
PDCD1 Q15116 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2278459 0.96 HDAC2 (0.71) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2270222 0.93 DHODH (0.77) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2272122 0.90 DHODH (0.57) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2275453 0.90 ACLY (0.76) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2270598 0.89 ACLY (0.71) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2272927 0.89 ACLY (0.64) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2271280 0.88 ACLY (0.62) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2272605 0.87 DHODH (0.73) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2273186 0.87 ACLY (0.68) ACLYDHODHHDAC2MEN1KMT2A
SCHEMBL2267918 0.86 ACLY (0.74) ACLYDHODHHDAC2KMT2ASERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
CN-101094829-A Novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2007-12-26 CN disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ACLY 653/4885DHODH 1469/4885HDAC2 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.